Literature DB >> 28303125

Antibiotic and Desiccation Resistance of Cronobacter sakazakii and C. malonaticus Isolates from Powdered Infant Formula and Processing Environments.

Peng Fei1, Yujun Jiang2, Jing Feng1, Stephen J Forsythe3, Ran Li1, Yanhong Zhou1, Chaoxin Man1.   

Abstract

This study evaluated the antimicrobial and desiccation resistance of Cronobacter sakazakii and Cronobacter malonaticus isolates from powdered infant formula and processing environments. The antimicrobial susceptibility tests showed that the 70 Cronobacter strains, representing 19 sequence types, were susceptible to the most of the antibiotics except for amoxicillin-clavulanate, ampicillin, and cefazolin. Furthermore, the growth of six C. sakazakii and two C. malonaticus strains from different sequence types (STs) in hyperosmotic media was measured. The growth of the two C. sakazakii strains (CE1 and CE13) from the neonatal pathovars ST4 and ST8, were significantly higher (p < 0.05) than that of other strains. C. malonaticus strain CM35 (ST201) was the slowest grower in all strains, and most could not grow in more than 8% NaCl solution. Also the survival of these strains under desiccation conditions was followed for 1 year. The viable count of Cronobacter spp. under desiccation conditions was reduced on average by 3.02 log cycles during 1 year, with CE13 (ST8) being the most desiccation resistant strain. These results will improve our understanding of the persistence of the two closely related species C. sakazakii and C. malonaticus which are of concern for neonatal and adult health.

Entities:  

Keywords:  C. malonaticus; C. sakazakii; antibiotic susceptibility; desiccation; powdered infant formula

Year:  2017        PMID: 28303125      PMCID: PMC5332417          DOI: 10.3389/fmicb.2017.00316

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


Introduction

Cronobacter spp. (formerly Enterobacter sakazakii) is an emerging opportunistic bacterial pathogen comprised of seven species: Cronobacter sakazakii, Cronobacter malonaticus, Cronobacter turicensis, Cronobacter muytjensii, Cronobacter condimenti, Cronobacter universalis, and Cronobacter dublinensis (Joseph et al., 2012b; Lu et al., 2014). This organism can cause necrotizing enterocolitis, bacteremia, and meningitis in neonates and infants, with a 40–80% mortality rate (Forsythe et al., 2014; Holy and Forsythe, 2014; Li et al., 2015). To date, only the three species C. sakazakii, C. malonaticus, and C. turicensis have been isolated from neonatal infections (Sonbol et al., 2013). Cronobacter spp. has been recovered from a wide variety of foods, with powdered infant formula (PIF) being of particular concern as it is the most significant source of Cronobacter strains resulting in neonatal infections (Iversen and Forsythe, 2004; Craven et al., 2010). Cronobacter strains cannot survive after the standard pasteurization procedures, therefore, the addition of non-heat treated materials and environmental contamination during filling and packaging are the plausible causes of Cronobacter contamination of PIF (Nazarowec-White and Farber, 1997). Besides, the strong resistant ability of the organism in dry PIF factory environments can increase the likelihood of post-pasteurization contamination (Riedel and Lehner, 2007). Currently, antibiotic therapy is considered to be the common and preferred way to prevent the Cronobacter infection in humans (Depardieu et al., 2007). Many studies have confirmed that Cronobacter strains can be effectively eliminated by antibiotics, however, prolonged use of antibiotics is undesirable as it may result in the development of Cronobacter antibiotic resistance (Yoneyama and Katsumata, 2006; McMahon et al., 2007). Hochel et al. (2012) reported that all of 53 Cronobacter strains isolated from 399 retail food samples were resistant to erythromycin, and two of them were resistant to both erythromycin and tetracycline. Chon et al. (2012) found that 77.8% Cronobacter strains isolated from desiccated foods in Korea were not susceptible to cephalothin. The Cronobacter strains resistance to cefotaxime and streptomycin have also been isolated from various foods in Korea and commercial PIF in China (Lee et al., 2012). Caubilla-Barron and co-workers reported that the C. sakazakii strains isolated from two fatal neonatal infections expressed β–lactamase activity (Caubilla-Barron et al., 2007). In addition, the effective dose of antibiotics for treatment may change after long-term antibiotic use, therefore screening environmental and PIF isolates of Cronobacter for antibiotic resistance would be a useful comparison with clinical isolates. The greater resistance of Cronobacter spp. to desiccation compared with other Enterobacteriaceae will enable their long term survival under a low water activity (aw) condition such as in PIF (aw: 0.2–0.5) which has a long shelf life of up to 1 year (Gurtler and Beuchat, 2007). In general, the viability of Cronobacter spp. in PIF decreases by 0.5–0.6 log cycles per month (Edelson-Mammel et al., 2005; Gurtler and Beuchat, 2007). Caubilla-Barron et al. (2007) found there was considerable reduction in the viable count of Cronobacter strains (about 3.34 log10 cycles) in the first 6 months, whereas after the following 24 months, the average reduction in viability decreased by 1.88 log10 cycles. It is important to note that some capsulated C. sakazakii strains were still recovered after 2.5 years, by contrast, both Salmonella enteritidis, and Escherichia coli were undetectable after 15 months (Barron and Forsythe, 2007). Some difference in desiccation resistance can be found among the different Cronobacter strains, for example, C. sakazakii NCTC11467T has atypical growth characteristics compared with most of Cronobacter strains, and cannot be recovered from desiccated condition after 1 year (Iversen et al., 2004). Cronobacter spp. produce highly mucoid colonies on milk agar plates and the capsular material could be linked to virulence traits such as macrophage survival as well as desiccation resistance (Ogrodzki and Forsythe, 2015). Particular capsule profiles correlate with the meningitic C. sakazakii pathovar clonal complex (CC) 4 (Ogrodzki and Forsythe, 2015). Cronobacter is a diverse genus and has been extensively studied using multilocus sequence typing for over 1,000 strains (Forsythe et al., 2014). This has revealed the high clonality within the genus as well as identified particular pathovars. C. sakazakii sequence type (ST) four identified using multi-locus sequence typing (MLST) was the dominant ST, and was associated with neonatal meningitis (Joseph and Forsythe, 2011). In addition, Cronobacter pathovars, associated with clonal complex are now recognized. Of particular relevance is the C. sakazakii CC4 pathovar which is associated with neonatal meningitis (Hariri et al., 2013; Forsythe et al., 2014). C. sakazakii ST8 and C. sakazakii ST1 were mainly isolated from clinical sources and PIF, respectively (Forsythe et al. 2014). C. sakazakii CC4 was also the genotype of ~25% of isolates recovered from the processing environment of PIF manufacturing plants (Sonbol et al., 2013). Why this CC predominates in PIF and neonatal infections is uncertain since no particular virulence genes have been detected (Joseph et al., 2012a). Therefore, a better understanding of the environmental fitness and antibiotic resistance of Cronobacter isolates with significant sequence type from PIF production areas is warranted. In previous studies, our group isolated 66 Cronobacter sakazakii and four C. malonaticus strains from PIF and processing environments from 2009 to 2012, and identified their sequence type by MLST (Fei et al., 2015). In this study, we further characterized the strains according to their antibiograms and desiccation tolerance, and considered whether the differences corresponded with their sequence type.

Materials and methods

Bacterial strains

A total of 70 Cronobacter strains (66 C. sakazakii and four C. malonaticus strains) were studied. All strains had been isolated from PIF and processing environments, as previously reported (Fei et al., 2015). All 70 Cronobacter strains were used for the antimicrobial assays, and six C. sakazakii (CE21, CE1, CE13, CE38, CE52, and CE25) and two C. malonaticus (CM3 and CM35) strains with different sequence types were selected for studying the survivals under desiccation condition. Strains were recovered from storage at −80°C in 40% (v/v) glycerol, by inoculating 0.1 mL portions of thawed cultures into 10 mL Luria-Bertani (LB) broth, followed by cultivation at 37°C for 12 h. The cultures were streaked onto Tryptic Soy Agar (TSA) plates and incubated at 37°C for 24 h for single colony isolation. A single colony of each strain was inoculated into the LB and incubated at 37°C for 18 h for following study.

Antimicrobial susceptibility testing

The antimicrobial susceptibility determination was performed using the BD PhoenixTM100 Automated Microbiology System (BD Diagnostic Systems, Sparks, MD) as according to the manufacturer's instructions. Twenty-one antibiotics were selected for the susceptibility test, including amikacin, amoxicillin-clavulanate, ampicillin, ampicillin-sulbactam, aztreonam, cefotaxime, ceftazidime, cefazolin, cefepime, chloramphenicol, ciprofloxacin, colistin, gentamicin, imipenem, levofloxacin, meropenem, moxifloxacin, piperacillin, piperacillin-tazobactam, tetracycline, and trimethoprim-sulfamethoxazole. The results were expressed as sensitive (S), intermediate (I), and resistant (R), and resistant according to the PhoenixTM100 guidelines. E. coli ATCC 25922 and E. coli ATCC 35218 were used as the quality control organisms, and were included in each run according to the manufacturer's recommendations.

Resistance to osmotic stress

For determining bacterial growth in a hyperosmotic environment, cultures (0.1 mL) were inoculated into brain–heart infusion (BHI) broth containing molar equivalents of either sodium chloride (NaCl) (4, 6, 8, 10% w/v) or sorbitol (12.5, 19, 25, 31% w/v). The above cultures were incubated at 37°C for 24 h, and subsequent growth was measured the growth according to the absorption values at 600 nm (OD 600) using an ultraviolet spectrophotometer (Biochrom Ltd., Cambridge, England). The “time to detection” (TTD), defined as the time (in h) to reach an OD 600 of 0.2, and “growth rate” (in h−1) were used to determine the growth of each strain under the different treatments, as previously reported (Alvarez-Ordonez et al., 2014).

Resistance to dry stress

C. sakazakii and C. malonaticus were grown in LB for 18 h at 37°C before analysis. For dry stresses, the cultures were harvested by centrifugation at 8,000 g for 10 min, then the cell pellets were diluted in 0.85% sterile normal saline (NS) to obtain a cell density of 8.00 log10 cfu/mL. The C. sakazakii and C. malonaticus cell suspensions were desiccated as previously described with minor modifications (Breeuwer et al., 2003). Unstressed cultures (50 μL) were transferred to sterile petri dishes without their lids, which were placed in a constant temperature humidity chamber, and incubated at 25°C with 20.7% air relative humidity (RH) for air-drying. After drying for 1.5 h, the petri dishes were covered and kept at 21°C with 20.7% RH for 1 year. Periodically, the bacterial survival was determined by conventional colony counting.

Statistical analysis

Mean values and standard deviations were obtained from three replicate experiments with duplicated plating (n = 6). Statistical analysis was performed by Analysis of Variance (ANOVA) with the SPSS 20.0 software. Tukey's multiple range test was used to determine the significant differences (p < 0.05) between treatments.

Results

Antimicrobial susceptibility tests

The antimicrobial susceptibility pattern and Minimal Inhibitory Concentration (MIC) of the 70 Cronobacter strains are shown in Tables 1, 2. All Cronobacter strains were susceptible to most antibiotics, including amikacin, ampicillin-sulbactam, aztreonam, cefepime, cefotaxime, ceftazidime, chloramphenicol, ciprofloxacin, colistin, gentamicin, imipenem, levofloxacin, meropenem, moxifloxacin, piperacillin, piperacillin- tazobactam, tetracycline, and trimethoprim-sulfamethoxazole. However, they were resistant to amoxicillin-clavulanate, ampicillin, and cefazolin. The MIC of antibiotics, except cefazolin, did not vary across the 70 Cronobacter strains. Ciprofloxacin and trimethoprim-sulfamethoxazole were considered to be the most effective antibiotics against the 70 Cronobacter strains at MIC of ≤ 0.5 and ≤ 0.5/0.95 μg/mL. In contrast, there were some differences in their resistance to cefazolin; Table 2. The 70 Cronobacter strains were divided into four groups according to their cefazolin MIC-values (≤4, >4, ≤8, >8, ≤16, >16 μg/mL). A majority of Cronobacter isolates with the same ST had a same MIC-value.
Table 1

Antimicrobial susceptibility and MIC of 70 .

AntibioticsMICa (μg/mL)SIRbAntibioticsMICa (μg/mL)SIRb
Amikacin≤8S (100%)Colistin≤0.5S (100%)
Amoxicillin-Clavulanate≤4/2R (100%)Gentamicin≤2S (100%)
Ampicillin≤4R (100%)Imipenem≤1S (100%)
Ampicillin-Sulbactam≤4/2S (100%)Levofloxacin≤1S (100%)
Aztreonam≤2S (100%)Meropenem≤1S (100%)
Cefotaxime≤1S (100%)Moxifloxacin≤1S (100%)
Ceftazidime≤1S (100%)Piperacillin≤4S (100%)
Cefepime≤2S (100%)Piperacillin-tazobactam≤4/4S (100%)
Chloramphenicol≤4S (100%)Tetracycline≤2S (100%)
Ciprofloxacin≤0.5S (100%)Trimethoprim-sulfamethoxazole≤0.5/0.95S (100%)

MIC: (Minimal Inhibitory Concentration) the lowest concentration of the antibiotics that can inhibit effectively growth of the tested microorganism.

S, Susceptible; I, Intermediate; R, Resistant.

Table 2

The differences of resistance to cefazolin in 70 .

MLSTStainMIC-1MIC-2MIC-3MIC-4MLSTStainMIC-1MIC-2MIC-3MIC-4
ST1CE21ST12CE41
CE24CE44
CE43ST17CE28
CE47CE58
CE59ST21CE51
CE60CE52
CE63CE53
CE69ST22CE15
CE70CE50
CE71ST31CE56
CE72ST40CE29
CE73ST50CE32
CE74ST64CE25
CE79CE30
ST4CE1CE31
CE7CE33
CE9CE34
CE10CE36
CE11CE54
CE12CE62
CE17CE68
CE18CE77
CE19CE78
CE20ST83CE8
CE22ST201CM35
CE23ST258CM2
CE27CM3
CE48CM5
CE49ST259CE16
CE61ST268CE26
CE64ST260CE55
CE67ST261CE75
ST8CE13CE76
CE14ST269CE65
ST12CE38CE66

Antimicrobial susceptibility and MIC of 70 . MIC: (Minimal Inhibitory Concentration) the lowest concentration of the antibiotics that can inhibit effectively growth of the tested microorganism. S, Susceptible; I, Intermediate; R, Resistant. The differences of resistance to cefazolin in 70 . Six C. sakazakii and two C. malonaticus strains were incubated in BHI with various molar equivalents of either NaCl or sorbitol at 37°C for 24 h. The TTD values and growth rates of eight Cronobacter strains are shown in Table 3. Compared with growth in BHI without high concentration solutes, the growth of all eight strains in BHI with different concentrations of NaCl and sorbitol was significantly delayed and slower. The TTD-values of all eight strains growing at >8% NaCl were >24 h, and the growth rates of those ranged from 0.0004/h to 0.0035/h. Meanwhile, in BHI with sorbitol, all strains reached an OD 600 of 0.2 within 12 h. This result showed that the growth of strains was not completely inhibited in <31% sorbitol, whereas there was no growth in the molar equivalent NaCl. In addition, there was variation between strains in their resistance to osmotic stress. Among the eight strains in this study, the growth of CE25 (ST64) was the most significantly delayed (p < 0.05), while CE13 (ST8) had more resistance to the delayed growth compared with other strains. The growth rates of CE13 (ST8) and CE1 (ST4) were significantly higher (p < 0.05) than that of other strains, and CM35 (ST201) was the slowest grower (p < 0.05) in all strains.
Table 3

Growth ability of the six .

Solute (w/v)Cronobacter strains
C. sakazakiiC. malonaticus
CE21 (ST1)CE1 (ST4)CE13 (ST8)CE38 (ST12)CE52 (ST21)CE25 (ST64)CM35 (ST201)CM3 (ST258)
TTD (h)Control (0%)33333333
NaCl (4%)75575996
NaCl (6%)1066128171411
NaCl (8%)>24>24>24>24>24>24>24>24
NaCl (10%)>24>24>24>24>24>24>24>24
SB (12.5%)53454555
SB (19%)75566777
SB (25%)87777899
SB (31%)119799121212
Growth RateControl (0%)0.064 ± 0.001a0.065 ± 0.003a0.064 ± 0.002a0.065 ± 0.002a0.064 ± 0.002a0.065 ± 0.002a0.065 ± 0.002a0.065 ± 0.001a
NaCl (4%)0.029 ± 0.003adef0.036 ± 0.002bce0.038 ± 0.003bc0.032 ± 0.004ade0.036 ± 0.002bce0.034 ± 0.002abde0.029 ± 0.003adef0.026 ± 0.002af
NaCl (6%)0.017 ± 0.002a0.030 ± 0.002b0.026 ± 0.001c0.020 ± 0.002d0.024 ± 0.002c0.018 ± 0.001a0.016 ± 0.002ae0.015 ± 0.002e
NaCl (8%)0.002 ± 0.000a0.004 ± 0.000b0.003 ± 0.000c0.001 ± 0.000d0.001 ± 0.000d0.001 ± 0.000d0.001 ± 0.000d0.001 ± 0.000d
NaCl (10%)0.001 ± 0.000a0.001 ± 0.000a0.001 ± 0.000a0.001 ± 0.000a0.001 ± 0.000a0.000 ± 0.000b0.0004 ± 0.000b0.000 ± 0.000b
SB (12.5%)0.053 ± 0.002a0.059 ± 0.001b0.058 ± 0.002b0.060 ± 0.001b0.060 ± 0.001b0.059 ± 0.001b0.048 ± 0.002c0.046 ± 0.002c
SB (19%)0.047 ± 0.001a0.051 ± 0.002bcd0.053 ± 0.002bc0.051 ± 0.001bcd0.052 ± 0.001bcd0.050 ± 0.002bd0.039 ± 0.001e0.037 ± 0.001e
SB (25%)0.040 ± 0.001a0.043 ± 0.001b0.045 ± 0.001c0.038 ± 0.001a0.039 ± 0.001a0.039 ± 0.001a0.030 ± 0.001d0.030 ± 0.001d
SB (31%)0.024 ± 0.001aeh0.035 ± 0.001b0.038 ± 0.001c0.026 ± 0.001de0.025 ± 0.001aeh0.028 ± 0.000f0.022 ± 0.000g0.025 ± 0.001aeh

All strains have different STs. The averages of three replications ± standard deviations were given. Rows values with the different letters were significant different (p < 0.05); The p value for each comparison is showed on each row.

Growth ability of the six . All strains have different STs. The averages of three replications ± standard deviations were given. Rows values with the different letters were significant different (p < 0.05); The p value for each comparison is showed on each row. The survival of six C. sakazakii and two C. malonaticus strains stored under desiccation condition (21°C, RH = 20.7%) was monitored for up to 1 year (Table 4). In the first 60 days, the average recovery declined by about 1.55 log cycles, then, a smaller decrease was observed during the next 10 months, ranging from 1.07 log cycles (CE13, ST8) to 1.85 log cycles (CE25, ST64). Within 1 year, the reduction of all strains ranged from 2.43 log cycles (CE13, ST8) to 3.46 log cycles (CE25, ST64). The survival of C. malonaticus CM3 (ST258) and C. sakazakii CE25 (ST64) were significantly less (p < 0.05) than the other six Cronobacter strains, and C. sakazakii CE13(ST8) was the highest (p < 0.05) survival in all eight Cronobacter strains. In addition, during the different time-phase in 1 year, the CM3 (ST258) had significant lower (p < 0.05) survival value compared with other strains.
Table 4

Survivors (log cfu/mL) of the six .

Time (days)Survivors (log cfu/mL)
C. sakazakiiC. malonaticus
CE21 (ST1)CE1 (ST4)CE13(ST8)CE38 (ST12)CE52 (ST21)CE25 (ST64)CM35 (ST201)CM3 (ST258)
08.008.008.008.008.008.008.008.00
67.81 ± 0.15a7.86 ± 0.11a7.88 ± 0.02a7.89 ± 0.03a7.81 ± 0.06a7.65 ± 0.03b7.77 ± 0.01a7.48 ± 0.05c
187.62 ± 0.04ad7.51 ± 0.04b7.70 ± 0.04cd7.81 ± 0.03d7.67 ± 0.04acd7.28 ± 0.04e7.53 ± 0.03b7.05 ± 0.05g
456.64 ± 0.16a7.10 ± 0.05b7.03 ± 0.05b7.14 ± 0.05b7.00 ± 0.04b6.65 ± 0.10a6.71 ± 0.06a6.24 ± 0.05c
606.45 ± 0.10abde6.58 ± 0.10abcd6.60 ± 0.10abcd6.62 ± 0.08bcd6.51 ± 0.07acde6.39 ± 0.09ade6.48 ± 0.13abcde6.07 ± 0.11f
906.29 ± 0.10abef6.47 ± 0.09abcdf6.51 ± 0.12bcdf6.50 ± 0.07bcdf6.38 ± 0.11abdf6.18 ± 0.10aef6.33 ± 0.08abcdef5.92 ± 0.16g
1206.11 ± 0.10ad6.28 ± 0.06bcd6.40 ± 0.07bc6.30 ± 0.09bcd6.11 ± 0.12ad6.07 ± 0.09ad6.21 ± 0.09abd5.81 ± 0.09e
1655.86 ± 0.10abe5.95 ± 0.11abd6.29 ± 0.13c6.11 ± 0.09bd5.85 ± 0.10abe5.77 ± 0.13ae5.89 ± 0.06abe5.31 ± 0.05f
2255.48 ± 0.12a5.38 ± 0.10a6.02 ± 0.10b5.85 ± 0.08c5.35 ± 0.11a5.38 ± 0.08a5.49 ± 0.06a5.02 ± 0.05d
2555.27 ± 0.13acd5.29 ± 0.11acd5.86 ± 0.10b5.72 ± 0.07b5.16 ± 0.08ac5.16 ± 0.06ac5.38 ± 0.11ad4.95 ± 0.09e
3654.96 ± 0.12a5.00 ± 0.08a5.57 ± 0.10b5.39 ± 0.10c4.86 ± 0.09a4.54 ± 0.09d4.97 ± 010a4.56 ± 0.11d
Total decrease3.04 ± 12a3.00 ± 0.08a2.43 ± 0.10b2.61 ± 0.10c3.14 ± 0.09a3.46 ± 0.09d3.03 ± 010a3.44 ± 0.11d

The averages of three replications ± standard deviations are shown. All strains have different STs. Rows values with the different letters were significant different (p < 0.05). The p value for each comparison is showed on each row.

Survivors (log cfu/mL) of the six . The averages of three replications ± standard deviations are shown. All strains have different STs. Rows values with the different letters were significant different (p < 0.05). The p value for each comparison is showed on each row.

Discussion

C. sakazakii and C. malonaticus are the dominant species of Cronobacter spp. isolated from PIF and processing environment, and can infect infants and adults, respectively (Fei et al., 2015). Given the long term shelf-life of PIF (up to 1 year) and repeated isolation from PIF production plants (Craven et al., 2010; Sonbol et al., 2013), environmental fitness of Cronobacter is very important trait to understand as it may lead to increased persistence and neonatal exposure. The phylogenetic relationship of concatenated sequences (3,036 bp) based on conventional MLST (7 loci), ribosomal-MLST (53 loci), and core genome MLST (1865 loci) reflects the whole genome phylogeny of the Cronobacter genus (Joseph et al., 2012b; Forsythe et al., 2014). The application of MLST has also led to the recognition of stable clonal complexes and sequence types associated with certain clinical presentations. Subsequently the diversity and clonal stability within the Cronobacter genus needs to be taken into consideration when interpreting laboratory studies. Therefore, Cronobacter strains with different sequence types were chosen for detailed study here. In this study, 70 Cronobacter strains, previously isolated from PIF and processing environments, were used. These represented 19 sequence types of C. sakazakii and C. malonaticus, detailed information can be obtained from Cronobacter MLST databases (http://pubmlst.org/cronobacter/) (Fei et al., 2015). The main STs from PIF and processing environments, were the neonatal pathovars C. sakazakii ST4, ST1, and ST8, as well as ST64, ST12, ST21, ST258, and ST201. The isolates were susceptible to most antibiotics, except for amoxicillin-clavulanate, and ampicillin. Previous reports revealed that the occurrence of susceptibility to cefotaxime, chloramphenicol, ciprofloxacin, gentamicin, and tetracycline in Cronobacter strains isolated from different sources (Chon et al., 2012; Xu et al., 2014). Chon et al. (2012) reported that only 5.6% strains from desiccated foods in Korea were resistance to ampicillin whereas in our study, all isolates were resistant to this antibiotic. Furthermore, we found that the MIC values of cefazolin varied across different STs, but were similar within each ST. This may reflect a connection between the ST and antimicrobial resistance. The ability of eight Cronobacter isolates with different STs to resist the osmotic stress was evaluated in this study. Compared with C. malonaticus isolates, C. sakazakii isolates had a higher capacity to grow in the hyperosmotic media, in agreement with previous studies (Caubilla-Barron et al., 2007; Avelino Alvarez-Ordóñez et al., 2014). C. sakazakii CE13 (ST8) was the most resistant to osmotic stress in the eight strains, interestingly, C. sakazakii ATCC 29544T reported to have atypical growth characteristics is also ST8 (Osaili and Forsythe, 2009). C. sakazakii CE1 (ST4) also showed a more osmotic stress resistance, which might be one of the major reasons why C. sakazakii CC4 is frequently isolated from infant food, ready-to-eat foods, potable water. This could result in higher infant exposure and therefore risk of infection (Forsythe et al., 2014). Cronobacter spp. tend to persist more in PIF with a water activity (aw) 0.25–0.30, compared with aw 0.43–0.50, and the survival rate was not associated with whether the PIF was milk-based or soybean-based (Osaili and Forsythe, 2009). In general, this organism can persist in PIF for more than 1 year, therefore, monitoring of survival under desiccated conditions is warranted for the two main Cronobacter species, C. sakazakii and C. malonaticus. Breeuwer et al. (2003) reported that the reduction of Cronobacter strains (species undetermined) which had been dried in air and incubated for 46 days at 25°C ranged from 1.0 to 1.5 log cycles. Using similar desiccation conditions, the viable counts of Cronobacter strains maintained at 25°C for 45 days decreased by 0.86–1.76 log cycles in our study. Barron and Forsythe (2007) reported that the number of survivors of C. sakazakii, C. muytjensis, and C. turicensis under desiccated conditions in the first 30 days reduced by 0.58 log cycles on average, and decreased 3.34 log cycles during the first 6 months. While, under the similar desiccation conditions, the results in current study indicated that the reduction of Cronobacter strains declined by an average of 0.86 log cycles during the first month, and 2.25 log cycles during the first 6 months. The differences in reduction of Cronobacter strains between different reports indicated that a continuous assessment of resistance to dry stress was very necessary. Interestingly, after kept in the desiccation conditions for 1 year, the total decrease of CE13 (ST8) was the least, followed by CE38 (ST12) and CE1 (ST4). This trend was similar to osmotic stress resistance. Mechanisms of resistance to these environmental stressor have previously been reviewed by Osaili and Forsythe (2009). The higher resistance to both osmotic and desiccation stresses by C. sakazakii compared with C. malonaticus may in part account for the predominance of C. sakazakii in PIF and processing environments and subsequent greater infant exposure. In summary, this study contributes to an improved understanding of the environmental persistence of C. sakazakii and C. malonaticus and subsequent risk of infant exposure through contaminated PIF. In addition, the relatively low antibiotic resistance is reassuring for the current treatment of Cronobacter infections.

Author contributions

Conceived and designed the experiments: CM and PF. Performed the experiments: PF, YJ, CM, JF, and YZ. Generated and analyzed the data: PF and RL. Wrote the paper: PF, CM, and SF.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
MIC-1(≤4 μg/mL)
MIC-2(> 4, ≤8 μg/mL)
MIC-3(> 8, ≤16 μg/mL)
MIC-4(> 16, μg/mL).
  26 in total

1.  Distribution, prevalence and persistence of Cronobacter (Enterobacter sakazakii) in the nonprocessing and processing environments of five milk powder factories.

Authors:  H M Craven; C M McAuley; L L Duffy; N Fegan
Journal:  J Appl Microbiol       Date:  2010-09       Impact factor: 3.772

Review 2.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Occurrence of Cronobacter spp. in retail foods.

Authors:  I Hochel; H Růžičková; L Krásný; K Demnerová
Journal:  J Appl Microbiol       Date:  2012-04-11       Impact factor: 3.772

4.  Comparison of methods for the microbiological identification and typing of Cronobacter species in infant formula.

Authors:  Y Lu; Y Chen; X A Lu; J Lv; C X Man; Y L Chai; Y J Jiang
Journal:  J Dairy Sci       Date:  2013-12-18       Impact factor: 4.034

5.  Identification of proteins involved in osmotic stress response in Enterobacter sakazakii by proteomics.

Authors:  Kathrin Riedel; Angelika Lehner
Journal:  Proteomics       Date:  2007-04       Impact factor: 3.984

6.  Genotypic and phenotypic analysis of Enterobacter sakazakii strains from an outbreak resulting in fatalities in a neonatal intensive care unit in France.

Authors:  J Caubilla-Barron; E Hurrell; S Townsend; P Cheetham; C Loc-Carrillo; O Fayet; M-F Prère; S J Forsythe
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

7.  Acid stress management by Cronobacter sakazakii.

Authors:  Avelino Alvarez-Ordóñez; Conor Cummins; Thérèse Deasy; Tanya Clifford; Máire Begley; Colin Hill
Journal:  Int J Food Microbiol       Date:  2014-03-11       Impact factor: 5.277

8.  Comparative analysis of genome sequences covering the seven cronobacter species.

Authors:  Susan Joseph; Prerak Desai; Yongmei Ji; Craig A Cummings; Rita Shih; Lovorka Degoricija; Alain Rico; Pius Brzoska; Stephen E Hamby; Naqash Masood; Sumyya Hariri; Hana Sonbol; Nadia Chuzhanova; Michael McClelland; Manohar R Furtado; Stephen J Forsythe
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

9.  Predominance of Cronobacter sakazakii sequence type 4 in neonatal infections.

Authors:  Susan Joseph; Stephen J Forsythe
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

10.  Cronobacter, the emergent bacterial pathogen Enterobacter sakazakii comes of age; MLST and whole genome sequence analysis.

Authors:  Stephen J Forsythe; Benjamin Dickins; Keith A Jolley
Journal:  BMC Genomics       Date:  2014-12-16       Impact factor: 3.969

View more
  16 in total

1.  Potential Mobilization of mcr-10 by an Integrative Mobile Element via Site-Specific Recombination in Cronobacter sakazakii.

Authors:  Jing Yang; Lina Liu; Yu Feng; Da He; Chengcheng Wang; Zhiyong Zong
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

2.  Identification and Characterization of Cronobacter Strains Isolated from Environmental Samples.

Authors:  Jinrui Hu; Xiaofang Li; Xiaoli Du; Zhigang Cui; Jinghua Cui
Journal:  Curr Microbiol       Date:  2019-10-04       Impact factor: 2.188

3.  Genomic Characterization of Cronobacter spp. and Salmonella spp. Strains Isolated From Powdered Infant Formula in Chile.

Authors:  Julio Parra-Flores; Ondřej Holý; Sergio Acuña; Sarah Lepuschitz; Ariane Pietzka; Alejandra Contreras-Fernández; Pamela Chavarría-Sepulveda; Ariadnna Cruz-Córdova; Juan Xicohtencatl-Cortes; Jetsi Mancilla-Rojano; Alejandro Castillo; Werner Ruppitsch; Stephen Forsythe
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

4.  Alterations in the Transcriptional Landscape Allow Differential Desiccation Tolerance in Clinical Cronobacter sakazakii.

Authors:  Yu Cao; Katherine Dever; Sathesh Kumar Sivasankaran; Scott V Nguyen; Guerrino Macori; Ankita Naithani; Gopal R Gopinath; Ben Tall; Angelika Lehner; Roger Stephan; Shabarinath Srikumar; Séamus Fanning
Journal:  Appl Environ Microbiol       Date:  2021-10-13       Impact factor: 5.005

5.  Genetic Diversity, Antimicrobial Susceptibility, and Biofilm Formation of Cronobacter spp. Recovered from Spices and Cereals.

Authors:  Yuanhong Li; Huan Yu; Hua Jiang; Yang Jiao; Yaodong Zhang; Jihong Shao
Journal:  Front Microbiol       Date:  2017-12-19       Impact factor: 5.640

6.  Prevalence, Molecular Characterization, and Antibiotic Susceptibility of Cronobacter sakazakii Isolates from Powdered Infant Formula Collected from Chinese Retail Markets.

Authors:  Peng Fei; Yichao Jiang; Yan Jiang; Xiujuan Yuan; Tongxiang Yang; Junliang Chen; Ziyuan Wang; Huaibin Kang; Stephen J Forsythe
Journal:  Front Microbiol       Date:  2017-10-17       Impact factor: 5.640

7.  DNA-Sequence Based Typing of the Cronobacter Genus Using MLST, CRISPR-cas Array and Capsular Profiling.

Authors:  Pauline Ogrodzki; Stephen J Forsythe
Journal:  Front Microbiol       Date:  2017-09-29       Impact factor: 5.640

8.  Prevalence and Molecular and Antimicrobial Characteristics of Cronobacter spp. Isolated From Raw Vegetables in China.

Authors:  Na Ling; Chengsi Li; Jumei Zhang; Qingping Wu; Haiyan Zeng; Wenjing He; Yingwang Ye; Juan Wang; Yu Ding; Moutong Chen; Liang Xue; Qinghua Ye; Weipeng Guo
Journal:  Front Microbiol       Date:  2018-06-05       Impact factor: 5.640

9.  Virulence and Antibiotic Resistance Profiles of Cronobacter sakazakii and Enterobacter spp. Involved in the Diarrheic Hemorrhagic Outbreak in Mexico.

Authors:  Julio Parra-Flores; Juan Aguirre; Vijay Juneja; Emily E Jackson; Ariadnna Cruz-Córdova; Jesus Silva-Sanchez; Stephen Forsythe
Journal:  Front Microbiol       Date:  2018-09-27       Impact factor: 5.640

10.  Cronobacter sakazakii and Microbiological Parameters in Dairy Formulas Associated With a Food Alert in Chile.

Authors:  Julio Parra-Flores; Fabiola Cerda-Leal; Alejandra Contreras; Nicole Valenzuela-Riffo; Alejandra Rodríguez; Juan Aguirre
Journal:  Front Microbiol       Date:  2018-07-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.